Mohammad Farhad

1.1k total citations
7 papers, 505 citations indexed

About

Mohammad Farhad is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Mohammad Farhad has authored 7 papers receiving a total of 505 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 4 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Mohammad Farhad's work include Cancer Immunotherapy and Biomarkers (3 papers), Immunotherapy and Immune Responses (3 papers) and Galectins and Cancer Biology (3 papers). Mohammad Farhad is often cited by papers focused on Cancer Immunotherapy and Biomarkers (3 papers), Immunotherapy and Immune Responses (3 papers) and Galectins and Cancer Biology (3 papers). Mohammad Farhad collaborates with scholars based in United States and Australia. Mohammad Farhad's co-authors include William L. Redmond, Annah S. Rolig, Charles G. Drake, Raymond C. Bergan, Tomasz M. Beer, Jeremy Cetnar, George Thomas, Rachel Slottke, Joshi J. Alumkal and Julie N. Graff and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and Oncotarget.

In The Last Decade

Mohammad Farhad

6 papers receiving 498 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mohammad Farhad United States	5	302	277	200	126	66	7	505
Takuro Yukawa Japan	13	232 0.8×	366 1.3×	202 1.0×	115 0.9×	98 1.5×	37	614
Jieti Wang China	15	318 1.1×	344 1.2×	147 0.7×	165 1.3×	99 1.5×	24	582
Mika Hoshino Japan	12	183 0.6×	308 1.1×	173 0.9×	169 1.3×	158 2.4×	36	538
Yelena Novik United States	11	200 0.7×	314 1.1×	150 0.8×	129 1.0×	79 1.2×	45	536
Hongyu Zhao China	7	312 1.0×	339 1.2×	91 0.5×	133 1.1×	63 1.0×	17	522
Cristina Migali Italy	12	198 0.7×	376 1.4×	86 0.4×	91 0.7×	66 1.0×	17	511
Zul Fazreen Singapore	6	167 0.6×	282 1.0×	122 0.6×	72 0.6×	52 0.8×	8	391
Alice Hervieu France	9	153 0.5×	235 0.8×	114 0.6×	129 1.0×	36 0.5×	31	395
Jun Osugi Japan	11	131 0.4×	209 0.8×	104 0.5×	164 1.3×	110 1.7×	31	412
Haruhisa Kitano Japan	11	166 0.5×	213 0.8×	109 0.5×	263 2.1×	87 1.3×	16	547

Countries citing papers authored by Mohammad Farhad

Since Specialization

Citations

This map shows the geographic impact of Mohammad Farhad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammad Farhad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammad Farhad more than expected).

Fields of papers citing papers by Mohammad Farhad

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohammad Farhad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammad Farhad. The network helps show where Mohammad Farhad may publish in the future.

Co-authorship network of co-authors of Mohammad Farhad

This figure shows the co-authorship network connecting the top 25 collaborators of Mohammad Farhad. A scholar is included among the top collaborators of Mohammad Farhad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohammad Farhad. Mohammad Farhad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Farhad, Mohammad, Annah S. Rolig, & William L. Redmond. (2018). The role of Galectin-3 in modulating tumor growth and immunosuppression within the tumor microenvironment. OncoImmunology. 7(6). e1434467–e1434467. 158 indexed citations

2.

Linch, Stefanie N., et al.. (2016). Combination OX40 agonism/CTLA-4 blockade with HER2 vaccination reverses T-cell anergy and promotes survival in tumor-bearing mice. Proceedings of the National Academy of Sciences. 113(3). E319–27. 66 indexed citations

3.

Graff, Julie N., Joshi J. Alumkal, Charles G. Drake, et al.. (2016). Early evidence of anti-PD-1 activity in enzalutamide-resistant prostate cancer. Oncotarget. 7(33). 52810–52817. 262 indexed citations

4.

Linch, Stefanie N., Melissa J. Kasiewicz, Michael J. McNamara, et al.. (2016). Galectin-3 inhibition using novel inhibitor GR-MD-02 improves survival and immune function while reducing tumor vasculature. The Journal of Immunology. 196(1_Supplement). 75.9–75.9. 3 indexed citations

5.

Linch, Stefanie N., et al.. (2015). Galectin-3 inhibition using novel inhibitor GR-MD-02 improves survival and immune function while reducing tumor vasculature. Journal for ImmunoTherapy of Cancer. 3(S2). 8 indexed citations

6.

Linch, Stefanie N., et al.. (2015). Combination OX40 agonism/CTLA-4 blockade with HER2 vaccination reverses T cell anergy and promotes survival in tumor-bearing mice. Journal for ImmunoTherapy of Cancer. 3(Suppl 2). P360–P360.

7.

Farhad, Mohammad, et al.. (2009). Studies on the Synthesis and Activity of Three Tripalladium Complexes Containing Planaramine Ligands. ChemMedChem. 4(11). 1841–1849. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact